Stay updated on Rituximab in Eosinophilic Granulomatosis Clinical Trial

Sign up to get notified when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab in Eosinophilic Granulomatosis Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:29:03.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The study record now shows Completed status, the primary completion date, enrollment, and a new 2025 publication summarizing the results.
    Difference
    0.1%
    Check dated 2026-03-18T13:44:31.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    - Revision: v3.4.3 replaces v3.4.2 as the page framework version.
    Difference
    0.1%
    Check dated 2026-03-11T14:41:17.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-lapse notice and the previous Revision: v3.4.1 text.
    Difference
    0.4%
    Check dated 2026-02-11T01:36:08.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and open-status update, and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T22:28:55.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Glossary, Related Info, sponsor affiliations (Assistance Publique - Hôpitaux de Paris), helpful links, and expanded drug/MeSH term listings have been added, along with IPD sharing plan details. The 'No FEAR Act data' entry has been removed.
    Difference
    61%
    Check dated 2026-01-27T19:54:34.000Z thumbnail image

Stay in the know with updates to Rituximab in Eosinophilic Granulomatosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.